BSE filing, NSE: SUNCLAY. Summary written from the filing by ALFA Finder's alert engine.
Sundaram-Clayton Ltd: key numbers
- Share price
- ₹1,088.60
- Market cap
- ₹2,400 Cr
- Revenue (annual)
- ₹2,026 Cr
- Net profit (annual)
- ₹252.4 Cr
- P/E (TTM)
- 9.6×Sector 30.9×
- Promoter holding
- 59.09%+0.00% QoQ
- FII holding
- 0.86%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sundaram-Clayton Ltd
All →Sundaram-Clayton Board Meeting Date
Sundaram-Clayton convenes a board meeting on 4 November 2026 to consider quarterly results. Trading window stays closed until 6 November 2026.
Sundaram-Clayton Other Announcement
Sundaram-Clayton filed its quarterly shareholding pattern for the period ending September 30, 2026, noting the cessation of VEE ESS Trading due to amalgamation.
Sundaram-Clayton Management Change
Mr. P Kaniappan has resigned as an Independent Director of Sundaram-Clayton Limited, effective 13th October 2026, to pursue other interests.
Sundaram-Clayton Annual General Meeting
Sundaram-Clayton Limited held its 9th Annual General Meeting on 28th July 2026. The meeting transacted business including the adoption of financial statements and re-appointments.
Sundaram-Clayton Results Update
Sundaram Clayton Limited reported a 19% revenue increase to ₹524.2 Crore for Q1 FY 2026-27. EBITDA stood at ₹66.5 Crore, impacted by higher input and logistic costs.
Sundaram-Clayton Q1 FY27 Results: Net Loss of ₹59.3 Cr, Loss Widens
Sundaram-Clayton Ltd reported revenue from operations of ₹591.6 Cr (+15.6% YoY) and a net loss of ₹59.3 Cr for Q1 FY27.
- Key figure
- Net loss ₹59.3 Cr
Other other announcement announcements
All →KRN Heat Exchanger and Refrigeration Other Announcement
KRN Heat Exchanger filed its Reg 32 statement confirming no deviation in QIP fund use, with INR 349.99 Crore raised on 1 June 2026. The utilisation table reports no variation across the three objects.
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.
- Value
- ₹95.00 Cr
NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Magson Retail & Distribution Other Announcement
Magson Retail submitted its Regulation 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. The report shows a 9,15,940 share difference between issued and listed capital, pending exchange listing approval.
Ekennis Software Service Other Announcement
Ekennis Software declared Regulation 23 related party transaction rules non-applicable for H1 FY27, as its paid-up capital and net worth are below SME thresholds. A CA certificate confirms the figures.